CannLabs Inc. (CANL) financial statements (2020 and earlier)

Company profile

Business Address 3888 E. MEXICO AVENUE
DENVER, CO 80210
State of Incorp. NV
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2015
TTM
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1133 
Cash and cash equivalents 1133 
Receivables 144  
Prepaid expense 107 
Total current assets: 26233 
Noncurrent Assets
Property, plant and equipment 99617732
Intangible assets, net (including goodwill) 21
Intangible assets, net (excluding goodwill) 21  
Other noncurrent assets 59 
Other undisclosed noncurrent assets (21)  
Total noncurrent assets: 1,05617732
TOTAL ASSETS: 1,31821032
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 9322215
Accounts payable  2215
Interest and dividends payable 3  
Other undisclosed accounts payable and accrued liabilities 930  
Debt 238 2
Due to related parties 219  
Deferred revenue and credits 120  
Other undisclosed current liabilities  8313
Total current liabilities: 1,50910630
Noncurrent Liabilities
Long-term debt and lease obligation 688  
Long-term debt, excluding current maturities 300  
Capital lease obligations 388  
Liabilities, other than long-term debt 750  
Due to related parties 750  
Total noncurrent liabilities: 1,438  
Other undisclosed liabilities (1,630)  
Total liabilities: 1,31710630
Stockholders' equity
Stockholders' equity attributable to parent, including: (1,629)1042
Preferred stock 1  
Common stock 651717
Additional paid in capital 6,6871,5841,403
Accumulated deficit (1,606)  
Other undisclosed stockholders' equity attributable to parent (6,775)(1,497)(1,417)
Stockholders' equity attributable to noncontrolling interest (1,630)  
Other undisclosed stockholders' equity 3,260  
Total stockholders' equity: 11042
TOTAL LIABILITIES AND EQUITY: 1,31821032

Income statement (P&L) ($ in thousands)

3/31/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Revenues 1,36584146
Revenue, net 1,365  
Financial services revenue  16 
Cost of revenue
(Cost of Goods and Services Sold)
 (887)  
Gross profit: 47884146
Operating expenses (3,666)(178)(173)
Other undisclosed operating income  16 
Operating loss: (3,188)(78)(26)
Nonoperating expense (55)(1) 
Other nonoperating expense  (1) 
Interest and debt expense (50)(1)(1)
Loss from continuing operations before income taxes: (3,293)(80)(28)
Income tax expense (benefit) 641 (5)
Loss before gain (loss) on sale of properties: (2,652)(80)(33)
Other undisclosed net loss (591)  
Net loss: (3,243)(80)(33)
Net income attributable to noncontrolling interest 1,658  
Other undisclosed net income (loss) attributable to parent (22)15
Net loss attributable to parent: (1,606)(79)(28)
Preferred stock dividends and other adjustments (22)  
Net loss available to common stockholders, diluted: (1,629)(79)(28)

Comprehensive Income ($ in thousands)

3/31/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Net loss: (3,243)(80)(33)
Comprehensive loss: (3,243)(80)(33)
Comprehensive income, net of tax, attributable to noncontrolling interest 1,658  
Comprehensive loss, net of tax, attributable to parent: (1,584)(80)(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: